STAT

STAT+: Pharmalittle: Global demand for Pfizer Covid-19 pill falls; biotech hub in Massachusetts set for a correction

Worldwide demand for the Pfizer Covid-19 antiviral pill has been unexpectedly light due to eligibility requirements, reduced testing, and potential drug interactions.
Source: Alex Hogan/STAT

Rise and shine, everyone, a busy day is on the way. We can tell thanks to the shimmering sounds of the street outside

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy Insurance Coverage, Zepbound Shortages, And More
The first major U.S. health insurers have agreed to start paying for the Wegovy weight loss drug for certain people on Medicare with heart conditions.
STAT1 min read
Opinion: HHS’s Proposed Rule Pays Lip Service To Addressing The Climate Crisis, The Greatest Threat To Human Health
HHS's proposal for addressing the climate crisis serves as an example of what historian and philosopher Hannah Arendt defined as the "banality of evil."
STAT1 min read
STAT+: Pharmalittle: We’re Watching A Ban Of Compounded Versions Of GLP-1s, A Biogen Acquisition, And More
Good morning from San Diego. This is Jonathan Wosen, West Coast biotech and life sciences reporter, filling in for Ed Silverman while he’s away from the Pharmalittle campus. I’m not a coffee drinker, but who needs caffeine when you’ve got the raw adr

Related Books & Audiobooks